Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It allows the drug to bind to human serum albumin in the bloodstream, extending its half-life to approximately five days and enabling once-weekly dosing
Weight reduction by 5 % to 10 % typically improves these odds, though for people with severe obesity (for example, BMI 35 kg/m), 15 % to 20 % weight loss is a more meaningful target
H tr iu tr v ngn nga mt s bnh lin quan n tim mch, bnh gan, ung th, bnh Alzheimer, vim xng khp v bnh Parkinson
Phase I dose-escalation study of MEDI-573, a bispecific, antiligand monoclonal antibody against IGFI and IGFII, in patients with advanced solid tumors
US$ 27.85
US$ 21.28
US$ 27.96
